Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

Detalles Bibliográficos
Autores principales: Dietrich, Martin F., Cavuoti, Dominick, Landay, Michael, Arriaga, Yull E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528877/
https://www.ncbi.nlm.nih.gov/pubmed/26425630
http://dx.doi.org/10.1177/2324709614560216
_version_ 1782384720631300096
author Dietrich, Martin F.
Cavuoti, Dominick
Landay, Michael
Arriaga, Yull E.
author_facet Dietrich, Martin F.
Cavuoti, Dominick
Landay, Michael
Arriaga, Yull E.
author_sort Dietrich, Martin F.
collection PubMed
description Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.
format Online
Article
Text
id pubmed-4528877
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-45288772015-09-30 Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition Dietrich, Martin F. Cavuoti, Dominick Landay, Michael Arriaga, Yull E. J Investig Med High Impact Case Rep Article Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab. SAGE Publications 2014-11-23 /pmc/articles/PMC4528877/ /pubmed/26425630 http://dx.doi.org/10.1177/2324709614560216 Text en © 2014 American Federation for Medical Research http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Article
Dietrich, Martin F.
Cavuoti, Dominick
Landay, Michael
Arriaga, Yull E.
Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title_full Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title_fullStr Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title_full_unstemmed Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title_short Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
title_sort histological regression of giant cell tumor of bone following rank ligand inhibition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528877/
https://www.ncbi.nlm.nih.gov/pubmed/26425630
http://dx.doi.org/10.1177/2324709614560216
work_keys_str_mv AT dietrichmartinf histologicalregressionofgiantcelltumorofbonefollowingrankligandinhibition
AT cavuotidominick histologicalregressionofgiantcelltumorofbonefollowingrankligandinhibition
AT landaymichael histologicalregressionofgiantcelltumorofbonefollowingrankligandinhibition
AT arriagayulle histologicalregressionofgiantcelltumorofbonefollowingrankligandinhibition

Ejemplares similares